United Health Products (UEEC) Return on Capital Employed (2011 - 2026)
United Health Products (UEEC) reported Return on Capital Employed of 26.4% for Q1 2026, down 16333.0% year-over-year from N/an in Q1 2025, and down 56.25% on a QoQ basis from 60.34% in Q4 2025.
United Health Products (UEEC) has 16 years of Return on Capital Employed data on file, last reported at 26.4% in Q1 2026.
- Quarterly Return on Capital Employed fell 16333.0% year-over-year to 26.4% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26.4% (down 16333.0% YoY) and the FY2025 annual result came in at 61.8%, down 8540.0% from the prior year.
- Return on Capital Employed fell to 26.4% in Q1 2026 per UEEC's latest filing, from 60.34% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 241.43% in Q3 2022 and bottomed at 26.4% in Q1 2026.
- The 5-year median for Return on Capital Employed is 145.67% (2023), against an average of 136.64%.
- The widest annual swing landed in 2022, when Return on Capital Employed plunged 8424466 bps; it then surged 8582 bps in 2025.
- Tracing UEEC's Return on Capital Employed over 5 years: stood at 139.11% in 2022, then gained by 6 bps to 147.94% in 2023, then retreated by 5 bps to 140.31% in 2024, then tumbled by 57 bps to 60.34% in 2025, then tumbled by 56 bps to 26.4% in 2026.
- Per Business Quant, the three latest UEEC Return on Capital Employed figures stand at 26.4% (Q1 2026), 60.34% (Q4 2025), and 144.71% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 5.02% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.95% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 18.63% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 19.44% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 6.60% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 12.74% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 13.02% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 12.04% |
| 10 | United Health Products | - | - | - | 26.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.40% |
| Dec 31, 2025 | 60.34% |
| Sep 30, 2025 | 144.71% |
| Jun 30, 2025 | 162.01% |
| Mar 31, 2025 | 189.73% |
| Dec 31, 2024 | 140.31% |
| Sep 30, 2024 | 79.50% |
| Jun 30, 2024 | 90.28% |
| Mar 31, 2024 | 103.91% |
| Dec 31, 2023 | 147.94% |
| Sep 30, 2023 | 150.96% |
| Jun 30, 2023 | 145.67% |
| Mar 31, 2023 | 148.57% |
| Dec 31, 2022 | 139.11% |
| Sep 30, 2022 | 241.43% |
| Jun 30, 2022 | 153.41% |
| Mar 31, 2022 | 198.53% |
| Dec 31, 2021 | 3,008.43% |
| Sep 30, 2021 | 3,545.47% |
| Jun 30, 2021 | 4,617.53% |
| Mar 31, 2021 | 84,443.19% |
| Dec 31, 2020 | 1,532.23% |
| Sep 30, 2020 | 1,036.92% |
| Jun 30, 2020 | 485.00% |
| Mar 31, 2020 | 602.51% |
| Dec 31, 2019 | 617.28% |
| Sep 30, 2019 | -922.97% |
| Jun 30, 2019 | -595.57% |
| Mar 31, 2019 | 879.92% |
| Dec 31, 2018 | 391.43% |
| Sep 30, 2018 | -157.58% |
| Jun 30, 2018 | 210.56% |
| Mar 31, 2018 | 127.50% |
| Dec 31, 2017 | 150.43% |
| Sep 30, 2017 | 69.59% |
| Jun 30, 2017 | -115.68% |
| Mar 31, 2017 | -112.81% |
| Dec 31, 2016 | 73.09% |
| Sep 30, 2016 | 95.05% |
| Jun 30, 2016 | 106.03% |
| Mar 31, 2016 | 141.42% |
| Dec 31, 2015 | 374.58% |
| Sep 30, 2015 | 645.72% |
| Jun 30, 2015 | 339.58% |
| Mar 31, 2015 | 358.96% |
| Dec 31, 2014 | 129.17% |
| Mar 31, 2013 | 11.64% |
| Dec 31, 2012 | 12.35% |
| Sep 30, 2012 | 28.74% |
| Jun 30, 2012 | 39.40% |
| Mar 31, 2012 | 53.95% |
| Dec 31, 2011 | 89.60% |
| Sep 30, 2011 | 124.91% |